Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation
Anticancer Research · 2026
DOI: 10.21873/anticanres.17946 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2026. Verfasst von Wataru Goto und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan. Hauptthemen laut MEDLINE: Breast Neoplasms, Cyclin-Dependent Kinase 4, Cyclin-Dependent Kinase 6, Protein Kinase Inhibitors.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Breast Surgical Oncology, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; spqv9ke9@view.ocn.ne.jp.
- Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
Zitieren
APA
Goto, W., Kashiwagi, S., Nishikawa, M., Watanabe, C., Takada, K., Tauchi, Y., Ogisawa, K., Shibutani, M., Kinoshita, H., & Morisaki, T. (2026). Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation. Anticancer Research. https://doi.org/10.21873/anticanres.17946
Vancouver
Goto W, Kashiwagi S, Nishikawa M, Watanabe C, Takada K, Tauchi Y, et al. Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation. Anticancer Research. 2026. doi:10.21873/anticanres.17946
BibTeX
@article{Goto2026,
author = {Goto, Wataru and Kashiwagi, Shinichiro and Nishikawa, Mariko and Watanabe, Chika and Takada, Koji and Tauchi, Yukie and Ogisawa, Kana and Shibutani, Masatsune and Kinoshita, Haruhito and Morisaki, Tamami},
title = {Radiological Complete Response as a Prognostic Marker in HR-positive Metastatic Breast Cancer Treated With CDK4/6 Inhibitors: Implications for Treatment De-escalation},
journal = {Anticancer Research},
year = {2026},
doi = {10.21873/anticanres.17946}
}
EUVIMED